Although the exact mechanism by which the NLRP3 inflammation contributes to the development of CAVD has not been thoroughly explored yet, one recent experiment suggested the involvement of NLRP3 (163). The gene discussed is NLRP3; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.